As of 2025-10-28, the EV/EBITDA ratio of Apyx Medical Corp (APYX) is -10.21. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Apyx's latest enterprise value is 121.40 mil USD. Apyx's TTM EBITDA according to its financial statements is -11.89 mil USD. Dividing these 2 quantities gives us the above Apyx EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 19.1x - 22.0x | 20.8x |
| Forward P/E multiples | 21.5x - 24.0x | 23.0x |
| Fair Price | (6.77) - (6.90) | (6.89) |
| Upside | -311.0% - -315.1% | -314.5% |
| Date | EV/EBITDA |